Approval · Notice of Compliance 11466 · 2010
EMLA: Notice of Compliance 11466
Issued May 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11466
- Date
- May 27, 2010
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update Product Monograph for safety changes
- Therapeutic class
- Topical anesthetic for dermal analgesia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMLA | Not yet assigned | — |
Medicinal ingredients
- LIDOCAINE 25 MG per G
- PRILOCAINE 25 MG per G
- LIDOCAINE 2.5 PER
- PRILOCAINE 2.5 PER